307 related articles for article (PubMed ID: 22753550)
1. Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Umaña J; Tate J; Lopman B; Sanchez E; Reyes M; Mercado J; Gonzalez A; Perez MC; Balmaceda A; Andrus J; Parashar U
Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550
[TBL] [Abstract][Full Text] [Related]
2. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U
JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.
Cardellino A; Khawaja S; Sánchez Cruz E; Mast TC
Hum Vaccin Immunother; 2013 Jul; 9(7):1449-53. PubMed ID: 23571175
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U
Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of monovalent and pentavalent rotavirus vaccine.
Cortese MM; Immergluck LC; Held M; Jain S; Chan T; Grizas AP; Khizer S; Barrett C; Quaye O; Mijatovic-Rustempasic S; Gautam R; Bowen MD; Moore J; Tate JE; Parashar UD; Vázquez M
Pediatrics; 2013 Jul; 132(1):e25-33. PubMed ID: 23776114
[TBL] [Abstract][Full Text] [Related]
10. Live attenuated human rotavirus vaccine, Rotarix.
Bernstein DI
Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
[TBL] [Abstract][Full Text] [Related]
11. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
[TBL] [Abstract][Full Text] [Related]
13. The pentavalent rotavirus vaccine, RotaTeq.
Matson DO
Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
[TBL] [Abstract][Full Text] [Related]
16. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.
Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932
[TBL] [Abstract][Full Text] [Related]
17. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
[TBL] [Abstract][Full Text] [Related]
18. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.
Field EJ; Vally H; Grimwood K; Lambert SB
Pediatrics; 2010 Sep; 126(3):e506-12. PubMed ID: 20732946
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.
Correia JB; Patel MM; Nakagomi O; Montenegro FM; Germano EM; Correia NB; Cuevas LE; Parashar UD; Cunliffe NA; Nakagomi T
J Infect Dis; 2010 Feb; 201(3):363-9. PubMed ID: 20047501
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
